TITLE

Treatment of cutaneous Crohn's disease with infliximab

AUTHOR(S)
Mitchell, Sara H; Varano, Vincent J; Komar, Michael J
PUB. DATE
September 2003
SOURCE
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS250
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article concerning infliximab treatment of cutaneous crohn's disease is presented.
ACCESSION #
66954759

 

Related Articles

  • Infliximab.  // Reactions Weekly;10/16/2010, Issue 1323, p25 

    The article describes the cases of two women who developed Lewis-Summer syndrome (LSS) while receiving treatment with infliximab for Crohn's disease (CD).

  • Infliximab.  // Reactions Weekly;5/15/2010, Issue 1301, p29 

    The article describes the case of two men who developed fulminant legionellosis after being given infliximab as treatment for Crohn's disease.

  • Healing of Crohn's disease enterovesical fistula, with the use of infliximab: a case report. Steinwurz, Flavio // American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS238 

    An abstract of the article concerning infliximab treatment of Crohn's disease is presented.

  • Infliximab treatment for Crohn's disease treated with elemental diet: the Tokyo experience. Tanaka, Torao; Takazoe, Masakazu; Morita, Eijirou; Terabe, Fumitaka // American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS252 

    An abstract of the article concerning infliximab treatment with elemental diet for Crohn's disease is presented.

  • Economic benefit of algorithm-based therapy after IFX failure.  // PharmacoEconomics & Outcomes News;Feb2015, Vol. 722 Issue 1, p14 

    The article reports on the Danish research indicating the economic advantage of individualised algorithm-based therapy after the failure of infliximab (IFX) in treating patients suffering from Crohn's disease.

  • Infusion reaction: case report.  // Reactions Weekly;5/7/2016, Vol. 1600 Issue 1, p118 

    An abstract of the article "Ustekinumab in treatment of refractory paediatric Crohn disease" by F.L. Infliximab Cameron and others is presented.

  • Infliximab-graded challenge in a patient with Crohn's disease and adalimumab hypersensitivity. Song, Christine H.; Quirt, Jaclyn A.; Lee, Jason K. // Allergy, Asthma & Clinical Immunology;2012, Vol. 8 Issue Suppl 1, p1 

    An abstract of the article "Infliximab-graded challenge in a patient with Crohn's disease and adalimumab hypersensitivity," by Christine H. Song, Jaclyn A. Quirt and Jason K. Lee is presented.

  • Severe polyneuropathy complicating active Crohn's disease: rapid response to Infliximab. Radiná, S.; Saccá, N.; D'Amico, T.; Fragomeni, A.; Giglio, A. // Gut;Jul2003, Vol. 52 Issue 7, p1070 

    Presents a letter to the editor published in the July 2003 issue of 'Gut' journal about the response of severe polyneuropathy complicating active Crohn's disease to infliximab.

  • Infliximab reduces resource use and costs in Crohn's disease.  // PharmacoEconomics & Outcomes News;6/29/2013, Issue 681, p3 

    The article discusses research being done on clinical outcomes and healthcare resource utilisation of infliximab treatment in Crohn's disease, which references a study by J. O. Lindsay et al. published in the May 23, 2013 issue of "Alimentary Pharmacology and Therapeutics."

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics